EHF technology system shows promising results for wounds and burns treatment
Nanomedic Technologies, which specialises in Electrospun Healing Fibre (EHF) technology for wound healing and skin regeneration, has announced the results of a new peer-reviewed study, showing promising results in the use of its Spincare System for the treatment of superficial to partial thickness wounds and burns.
The single-centre prospective observational trial, published in Annals of Burns and Fire Disasters, the official publication of the Euro-Mediterranean Council for Burns and Fire Disasters and the European Burns Association, revealed that the Spincare polymer nanofibrous dressing (PND) allows for a maximum range of motion, is suitable for covering all wound types and attaches well on to wound surfaces throughout the entire healing period.
Dr. Alexandra Schulz, principal author of the study at the Cologne-Merheim Medical Centre, said: “As electrospinning technology has recently gained increased attention, we were eager to explore the potential use of the new Spincare System for treating a range of burns and wounds. We found the system easy to use and were pleased to see that the nanofibrous layer is suitable for multiple cases, including following enzymatic debridement in burn wounds, yielding promising results for the treatment of superficial to partial thickness wounds.”
The four-month clinical study evaluated treatment results from 10 patients between 19 and 76 years of age. Subjects treated suffered from superficial to partial thickness wounds including split-thickness donor sites burns. Treatment was evaluated, including procedures, place of injury, treatment times, and ease of use. Researchers quickly mastered handling the Spincare System, and the PND was applied between the day of injury and up to 21 days post injury. No adverse events or signs of infection were found in any cases treated. Overall conclusions found the Spincare PND to be a patient friendly, customised temporary epidermal layer for treatment of superficial to partial thickness wounds including burns.
Dr. Chen Barak, chief executive officer of Nanomedic, said: “We are encouraged by these study results evaluating Spincare’s ease of use and efficacy on human donor sites and burn wounds. Our solution provides an easy one-time application for improved treatment of wounds, while allowing patients to quickly return to active life, with improved mobility and excellent healing and scarring. We are pleased that the Cologne-Merheim Medical Centre has tested our device and are working on additional clinical studies with medical facilities across the globe.”
Next steps of the evaluation will be presented in a few months and will include treatment of superficial to partial thickness burns with PND on a larger scale, with emphasis placed on healing time and long-term scarring.